To include your compound in the COVID-19 Resource Center, submit it here.

EOC Pharma raises $32M series B

On Nov. 7, EOC Pharma Group (Shanghai, China) raised $32 million in a series B round led

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE